FDA Panel Eyes Popular Peptides Amid Growing Demand

The FDA is convening a panel to review popular peptide products as consumer interest in these compounds continues to surge. The regulatory review comes as demand for peptides remains strong in the marketplace. The panel's examination will likely focus on safety, efficacy, and proper classification of these products. This regulatory action reflects growing scrutiny of the peptide market despite persistent consumer appetite.